LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. The Company's product portfolio includes the LENSAR Laser System and the ALLY Robotic Cataract Laser System and their associated consumable components. It has developed its ALLY System as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating artificial intelligence into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing its advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite. ALLY allows the surgeon to switch between cataract laser and the surgeon’s existing phacoemulsification device without moving patients from room-to-room. ALLY includes its proprietary Streamline software technology.
Company Information
About this company
Key people
William J. Link
Independent Chairman of the Board
Nicholas T. Curtis
Chief Executive Officer, Director
Michael A. Rossi
Interim Chief Financial Officer and Principal Financial Officer
Alan B. Connaughton
Chief Operating Officer
Thomas B. Ellis
Independent Director
Todd B. Hammer
Independent Director
Richard L. Lindstrom
Independent Director
Elizabeth G. O'Farrell
Independent Director
Click to see more
Key facts
- Shares in issue12.10m
- EPICLNSR
- ISINUS52634L1089
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$69.48m
- Employees150
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.